The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

Irit Avivi; Moshe E. Gatt; Efrat Luttwak; Hila Magen; Najib Dally; Yael C. Cohen; Noam Benyamini; Noa Lavi

doi:10.1016/j.leukres.2020.106429

The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

Irit Avivi
, Moshe E. Gatt
, Efrat Luttwak
, Hila Magen
, Najib Dally
, Yael C. Cohen
, Noam Benyamini
, Noa Lavi^*

^*Corresponding author for this work

Faculty of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Article number	106429
Journal	Leukemia Research
Volume	97
DOIs	https://doi.org/10.1016/j.leukres.2020.106429
State	Published - Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Levofloxacin prophylaxis
Venetoclax
relapsed/refractory multiple myeloma
t(11;14)

Access to Document

10.1016/j.leukres.2020.106429

Cite this

@article{d6b532a7e5194693a9608319e085a290,

title = "The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data",

keywords = "Levofloxacin prophylaxis, Venetoclax, relapsed/refractory multiple myeloma, t(11;14)",

author = "Irit Avivi and Gatt, \{Moshe E.\} and Efrat Luttwak and Hila Magen and Najib Dally and Cohen, \{Yael C.\} and Noam Benyamini and Noa Lavi",

year = "2020",

month = oct,

doi = "10.1016/j.leukres.2020.106429",

language = "אנגלית",

volume = "97",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias

T2 - Real-life data

AU - Avivi, Irit

AU - Gatt, Moshe E.

AU - Luttwak, Efrat

AU - Magen, Hila

AU - Dally, Najib

AU - Cohen, Yael C.

AU - Benyamini, Noam

AU - Lavi, Noa

PY - 2020/10

Y1 - 2020/10

KW - Levofloxacin prophylaxis

KW - Venetoclax

KW - relapsed/refractory multiple myeloma

KW - t(11;14)

UR - https://www.scopus.com/pages/publications/85089809782

U2 - 10.1016/j.leukres.2020.106429

DO - 10.1016/j.leukres.2020.106429

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32861018

AN - SCOPUS:85089809782

SN - 0145-2126

VL - 97

JO - Leukemia Research

JF - Leukemia Research

M1 - 106429

ER -

The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

UN SDGs

Keywords

Access to Document

Other files and links

Cite this